Key points are not available for this paper at this time.
In patients with invasive aspergillosis, initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B.
Herbrecht et al. (2002) studied this question.